Cataldo, Maria Letizia
 Distribuzione geografica
Continente #
NA - Nord America 76
AS - Asia 48
EU - Europa 18
Totale 142
Nazione #
US - Stati Uniti d'America 76
SG - Singapore 25
HK - Hong Kong 14
IT - Italia 13
VN - Vietnam 4
JP - Giappone 2
NL - Olanda 2
PK - Pakistan 2
AT - Austria 1
CN - Cina 1
DE - Germania 1
FI - Finlandia 1
Totale 142
Città #
Singapore 15
Hong Kong 14
Santa Clara 10
Millbury 8
Lawrence 5
Dong Ket 4
Chandler 3
Giugliano In Campania 3
Amsterdam 2
Ashburn 2
Boston 2
Des Moines 2
Kagoya 2
Lahore 2
Dearborn 1
Formia 1
Houston 1
Lappeenranta 1
Nanjing 1
Naples 1
Napoli 1
Nuremberg 1
Seattle 1
Trecase 1
Wilmington 1
Totale 85
Nome #
Activation of the IFN signaling pathway is associated with resistance to CDK4/6 inhibitors and immune checkpoint activation in ER-positive breast cancer 34
The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance 30
NPY1R exerts inhibitory action on estradiol-stimulated growth and predicts endocrine sensitivity and better survival in ER-positive breast cancer 24
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 23
Evaluation of the predictive role of tumor immune infiltrate in HER2-positive breast cancer patients treated with neoadjuvant anti-HER2 therapy without chemotherapy 20
The effect of the alpha-specific PI3K inhibitor alpelisib combined with anti-HER2 therapy in HER2+/PIK3CA mutant breast cancer 17
High FOXA1 levels induce ER transcriptional reprogramming, a pro-metastatic secretome, and metastasis in endocrine-resistant breast cancer 5
Totale 153
Categoria #
all - tutte 825
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 825


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 0 0 0 0 0 1 0 1
2020/20218 0 0 0 0 0 0 1 0 2 0 0 5
2021/202242 1 0 7 0 3 0 3 1 2 0 13 12
2022/202315 5 1 1 0 0 1 0 1 1 2 1 2
2023/202433 2 6 5 4 1 2 1 0 0 0 9 3
2024/202549 9 9 0 0 0 8 23 0 0 0 0 0
Totale 153